Home/Pipeline/MVR-C5252

MVR-C5252

Glioblastoma and other CNS tumors

Phase 1Active

Key Facts

Indication
Glioblastoma and other CNS tumors
Phase
Phase 1
Status
Active
Company

About ImmVira

Clinical-stage biotech developing engineered oncolytic herpes simplex virus therapies for solid tumor cancers.

View full company profile

Therapeutic Areas